Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients
Marta Kantauskaitė, Lisa Müller, Thilo Kolb, et al.
American Journal of Transplantation (2021) Vol. 22, Iss. 2, pp. 634-639
Open Access | Times Cited: 124

Showing 1-25 of 124 citing articles:

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
BMJ (2022), pp. e068632-e068632
Open Access | Times Cited: 395
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
Luuk Wieske, Koos P J van Dam, Maurice Steenhuis, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 5, pp. e338-e350
Open Access | Times Cited: 113
Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant
Kasama Manothummetha, Nipat Chuleerarux, Anawin Sanguankeo, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e226822-e226822
Open Access | Times Cited: 91
The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic
Ailish Nimmo, Dale Gardiner, Ines Ushiro‐Lumb, et al.
Transplantation (2022) Vol. 106, Iss. 7, pp. 1312-1329
Open Access | Times Cited: 81
Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients
Eva Schrezenmeier, Héctor Rincón-Arévalo, Annika Jens, et al.
JCI Insight (2022) Vol. 7, Iss. 9
Open Access | Times Cited: 80
The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation
Camille N. Kotton, Nassim Kamar, David Wojciechowski, et al.
Transplantation (2024) Vol. 108, Iss. 9, pp. 1834-1866
Open Access | Times Cited: 44
Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients
Louise Benning, Christian Morath, Marie Bartenschlager, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 7, pp. 1873-1883
Open Access | Times Cited: 46
Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis
Xinpei Chen, De Luo, Bingjie Mei, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 4, pp. 441-456
Open Access | Times Cited: 45
Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients
Aenne Harberts, Golda Schaub, Darius F. Ruether, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 20, Iss. 11, pp. 2558-2566.e5
Open Access | Times Cited: 37
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis
Hari Shankar Meshram, Vivek Kute, Hemant Rane, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 6
Open Access | Times Cited: 31
Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients
A. Lianne Messchendorp, Jan‐Stephan Sanders, Alferso C Abrahams, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 114-114
Open Access | Times Cited: 6
Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination—A Non-randomized, Controlled Pilot Study
Florina Regele, Andreas Heinzel, Karin Hu, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 28
Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination
Ayman Al Jurdi, Rodrigo Benedetti Gassen, Thiago J. Borges, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Perspectives on Mycophenolate Mofetil in the Management of Autoimmunity
R. G. Bhat, Antonio Tonutti, Suraj Timilsina, et al.
Clinical Reviews in Allergy & Immunology (2023) Vol. 65, Iss. 1, pp. 86-100
Closed Access | Times Cited: 15
Immune Response to COVID-19 mRNA Vaccination in Previous Nonresponder Kidney Transplant Recipients After Short-term Withdrawal of Mycophenolic Acid 1 and 3 Months After an Additional Vaccine Dose
Tessa Kühn, Claudius Speer, Christian Morath, et al.
Transplantation (2023) Vol. 107, Iss. 5, pp. 1139-1150
Open Access | Times Cited: 14
Persistent SARS-CoV-2–specific immune defects in kidney transplant recipients following third mRNA vaccine dose
William A. Werbel, Andrew H. Karaba, Teresa Po‐Yu Chiang, et al.
American Journal of Transplantation (2023) Vol. 23, Iss. 6, pp. 744-758
Open Access | Times Cited: 14
Impaired Humoral Response to Third Dose of BNT162b2 mRNA COVID-19 Vaccine Despite Detectable Spike Protein–specific T cells in Lung Transplant Recipients
Jan Havlín, Aneta Skotnicová, Eliška Dvořáčková, et al.
Transplantation (2021) Vol. 106, Iss. 3, pp. e183-e184
Open Access | Times Cited: 31
Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients
Jackrapong Bruminhent, Chavachol Setthaudom, Rungthiwa Kitpermkiat, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases
Maria De Santis, Francesca Motta, Natasa Isailovic, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 801-801
Open Access | Times Cited: 21
Risk Factors for Weak Antibody Response of SARS-CoV-2 Vaccine in Adult Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis
Kezhen Zong, Dadi Peng, Hang Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acid
Louise Benning, Christian Morath, Tessa Kühn, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 20
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
Lena Jaki, Sebastian Weigang, Lisa Kern, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Comparison of immune responses to SARS-CoV-2 spike following Omicron infection or Omicron BA.4/5 vaccination in kidney transplant recipients
Inga Tometten, Tobias Brandt, Maike Schlotz, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Impact of immunosuppressive regimens on antibody response after COVID-19 vaccination among Thai kidney transplant recipients
Nuttasith Larpparisuth, Kritsada Pongsakornkullachart, Nartsiri Ratchawang, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e42291-e42291
Open Access
Besonderheiten des Impfens nach Nierentransplantation
S. Jansen, Christian Weber, Hana Rohn, et al.
Nephrologie aktuell (2025) Vol. 29, Iss. 01, pp. 24-31
Closed Access
Page 1 - Next Page

Scroll to top